Somnus Therapeutics, Inc. (Bedminster, NJ) is a private drug development company formed by Care Capital LLC. The company is developing an improved therapeutic to address the top need of insomnia patients: preventing mid-night awakenings without next-day hangovers.
By leveraging the development of a chemical entity from the most successful class of current insomnia drugs with
we believe we can speed development and reduce clinical development costs, thus increasing return on investment.
technical advances in formulation